Lung Cancer Trial, Not Yet Recruiting NCT06711939 Sponsor: Mitera Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT06711939
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 18 and 75 years of age, of any gender.
  • People who are able to communicate and understand information provided by the MITERA staff.
  • People who have been diagnosed with the condition being studied in this trial.
  • People whose condition is at an early stage and who have not yet started any treatment for it.
  • People who do not have other serious health conditions that could affect the measurements taken in the study.
  • Healthy volunteers of any gender, aged between 20 and 75 years, who do not have the condition being studied, may also be considered for participation alongside patients.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have not signed a consent form agreeing to take part.
  • People who are unable to cooperate with the study for any reason.
  • People who have not followed the required instructions before providing a breath sample.
  • People who are unable to provide a reliable breath sample.
  • People who have started a new treatment, special diet, surgery, or other health intervention between the time their breath samples are collected.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +30 6973989859

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Mitera Hospital
Registry
ClinicalTrials.gov
Start date
9 December 2024
Est. completion
31 August 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Vocorder valistion in clinical practice

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov